|
Abbott Laboratories - Testing, Treatment and Quality of Life: Achieving Long-Term Clinical Success in HIV |
MOSA4 |
|
| Type: |
|
| Venue: |
Parkside Auditorium |
|
|
| Time: |
18:30 - 20:30, Monday, 23.07.2007 |
| Code: |
MOSA4 |
|
Chairperson: |
Andrew Carr, Australia
|
|
|
The session will be divided in three parts:
One will talk about Lipoatrophy. Explaining what it is and what it could involve for patients’ quality of life. The talk will also analyze the latest data available regarding HIV therapy and its impact on this disorder.
The second part will dwell on glucose metabolism, showing the latest research on HIV patients.
The third part will mainly go over the impact of Non-B HIV subtypes on HIV diagnostics and viral load testing
|
|
Presentations in this session:
MOSA402 | Glucose Metabolism: Implications for HIV Treatment
Judith Aberg, United States
|
MOSA401 | Lipoatrophy: Diagnosis and Clinical Management
Eric Daar, Germany
|
MOSA403 | Viral Variability: HIV’s Challenge to Viral Load and Diagnostic Testing.
Phillip Hay, St George's Hospital, United Kingdom
|
|